EL PASO, TX--(Marketwired - Nov 9, 2016) - Premier Biomedical, Inc. (
William A. Hartman, President and CEO of Premier Biomedical, stated, "This is a tremendous opportunity for us to get a better picture of this growing segment of the all-natural-ingredient pain management industry, from scouting the competition, to benchmarking competitive products and establishing key contacts with suppliers, distributors, and potential customers. The experience gathered at this conference will also assist us in our on-going efforts to launch products to compete in the $112 billion global pain management market. Our initial product sales are slated to begin in just a few weeks, in January, 2017, with continuing multiple product launches throughout 2017. The products we will be launching include a 96-hour pain patch versus the competition at 6-12 hours, roll-ons, creams, sprays, lip balms and capsules."
Ronald T. LaBorde, Managing Director of Premier's Pain Management Solutions Joint Venture, said, "This is the premier event in the cannabis industry. Every serious player in the industry from growers, to manufacturers, to investors, to distributors and customers attend this event -- a veritable Who's Who of the industry. This conference comes at exactly the right time for us, as we are in the process of launching our global manufacturing and marketing strategies for our products."
About Premier Biomedical, Inc.
Premier Biomedical, Inc. (
Safe Harbor Notice
Certain statements contained herein are "forward-looking statements" (as defined in the Private Securities Litigation Reform Act of 1995). Premier Biomedical, Inc. cautions that statements, and assumptions made in this news release constitute forward-looking statements and makes no guarantee of future performance. Forward-looking statements are based on estimates and opinions of management at the time statements are made. These statements may address issues that involve significant risks, uncertainties, estimates made by management. Actual results could differ materially from current projections or implied results. Premier Biomedical, Inc. undertakes no obligation to revise these statements following the date of this news release.
Contact:
William A. Hartman
President & CEO
Premier Biomedical, Inc.
Contact Info: (724) 633-7033
[email protected]
We use cookies to tailor your experience, measure site performance and present relevant offers and advertisements. By clicking ‘Accept’ or any content on this site, you agree that cookies can be placed on your browser. You can view our privacy policy to learn more.
If you would like to get more data, alerts and access to Real Vision videos, join us as an Insider Tracking Advantage Ultra member